Abstract
Elexacaftor/Tezacaftor/Ivacaftor (ETI) is a recently approved cystic fibrosis (CF) transmembrane conductance regulator modulator therapy that has show......
小提示:本篇文献需要登录阅读全文,点击跳转登录